TRAF6 peptide
TRAF6 peptide is a specific TRAF6-p62 inhibitor. TRAF6 peptide potently abrogates NGF-dependent TrkA ubiquitination. TRAF6 peptide has good research potential in neurological diseases such as alzheimer's disease (AD), parkinson's, ALS, head trauma, epilepsy and stroke.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 852805-92-6
- Formule: C145H238N34O44
- Masse moléculaire:3161.64
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
TRAF6 peptide (150 µM; 5 h) blocks the interaction of p62 with TRAF6 in PC12 cells[1].
TRAF6 peptide eliminates TRAF6 and UbcH7 from interacting with TrkA and can ffectively abolish NGF-dependent ubiquitination of TrkA in vitro[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PC12 cells
-
Concentration:150 µM
-
Incubation Time:5 h
-
Result:Inhibited the interaction of p62 with TRAF6 by immunoprecipitating TRA F6.
Chemical Information
-
CAS No. 852805-92-6
-
Masse moléculaire 3161.64
-
Formule C145H238N34O44
-
Sequence Shortening
AAVALLPAVLLALLAPESASGPSEDPSVNFLK
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)